OSR (OSRH) Stock Price, News & Analysis

Company Overview

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

Key Stats

• Today's Range: $1.35 to $1.44
• 50-Day Range: $1.33 to $3.79
• 52-Week Range: $1.25 to $13.40
• Volume: 121,057 shs
• Average Volume: 3.69 million shs
• Market Capitalization: $5.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OSRH Stock Analysis - Frequently Asked Questions

How have OSRH shares performed this year?

OSR's stock was trading at $4.22 at the beginning of 2025. Since then, OSRH shares have decreased by 66.6% and is now trading at $1.41.
View the best growth stocks for 2025 here.

How do I buy shares of OSR?

Shares of OSRH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Holding & other investment offices
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:OSRH
• CIK: 1840425
• Web: N/A
• Phone: (425) 635-7700
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $4.89 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,041,000
• Free Float: 2,680,000
• Market Cap: $5.70 million
• Optionable: N/A
• Beta: 1.41